Oncology
Video - MoonRISe-3: a Phase 3 Study of Erda-iDRS, an Erdafitinib Intravesical Drug-Releasing System, vs Intravesical Chemotherapy in Patients With Bacillus Calmette-Guérin–Treated High-Risk Non–Muscle-Invasive Bladder Cancer With Susceptible FGFR Alterations